Please login to the form below

Aptalis

This page shows the latest Aptalis news and features for those working in and with pharma, biotech and healthcare.

HIV prevention pill heads July CHMP recommendations

Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

Latest news

Actavis claims top UK generics spot with Auden Mckenzie buy

Other acquisitions in the last 12 months have included $25bn for Forest Laboratories, $2.9bn for Aptalis, a $1.6bn deal for Furiex Pharma and $675m for Durata.
Forest Labs agrees $1.46bn deal to buy Furiex

Forest chief executive Brent Saunders said the Furiex deal "is a natural extension of our GI business following our $2.9bn acquisition of Aptalis earlier this year," adding that eluxadoline would
Forest said to be interested in $3bn Aptalis acquisition

The private equity group bought Aptalis for $1.3bn in 2008 and was looking to sell it on for $3bn-$4bn. ... The Aptalis rumour also comes shortly after Forest itself was the subject of speculation about a possible takeover by AstraZeneca.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Pharma deals during February 2014

The announcement came just after Forest completed its acquisition of Aptalis last month for $3bn and this month sold a number of products to Hospira's Australian subsidiary Mayne Pharma for
Pharma deals during January 2014

Almost right to the end of the month, the big headline deal was that of Forest with its planned takeover of Aptalis. ... Aptalis itself was only formed in 2011 following the acquisition of Eurand by the Montreal based Axcan Pharma.
Deal Watch table for January 2014

4, 295. Aptalis/ Forest. Company acquisition. Acquiring sales turnover of $688m. 2, 900.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

He has held numerous leadership roles including president and CEO of Aptalis Pharma prior to its acquisition by Forest Laboratories.
Lupin names chief corporate development officer

Theresa Stevens has experience at Novartis and Aptalis. Lupin has appointed Theresa Stevens as chief corporate development officer for its global operations. ... Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief
Marino Garcia joins Synergy Pharmaceuticals

Garcia joins the New York-based gastrointestinal specialist from Aptalis Pharma, which also focused on the gastrointestinal market, as well as cystic fibrosis. ... Prior to his time at Aptalis Garcia was VP of US commercial operations and new product

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director, Medical Education: Salary TBC

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Scientific Director - Medical Communications - Berkshire: Excellent package on offer

Graduate Scientific Editor: DOE

Senior Medical Writer: Salary TBC

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Account Director: Salary TBC

Account Supervisor: Salary TBC

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Account Executive: Salary TBC

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Medical Writer – Very Flexible Working – Surrey: Negotiable

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Entry Level Editorial Assistant – Medical Education –Buckinghams...: Highly Competitive

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Editorial Team Leader – Medical Communications – Buckinghamshire...: Salary TBC

Senior Editor - Medical Communications - South East - Buckingham...: Highly competitive salary &package

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Subscribe to our email news alerts

PMHub

Add my company

Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Using human insights to push healthcare communications forward: This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy: The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail: We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...